Busted again. Sorry you don't recognize junk science when

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks copytele #117923
186
Busted again. Sorry you don't recognize junk science when you see it, or don't even fact check it. And seriously, do you think that you're educated well enough to understand the following?

No, COVID-19 vaccines aren’t gene therapy

CLAIM: The COVID-19 vaccines “are a gene therapy, NOT a vaccine.”

https://apnews.com/article/fact-check-covid-v...6280914802

AP’S ASSESSMENT: False. The COVID-19 vaccines do not change a person’s genes, as gene therapy does, experts say. The shots from Pfizer and Moderna use messenger RNA, or mRNA, to instruct the body to create a protein from the coronavirus. The Johnson & Johnson vaccine, meanwhile, uses a modified adenovirus to trigger an immune response.

THE FACTS: False claims that the vaccines alter humans’ DNA have circulated since before their debut in late 2020.

In recent days, social media posts have shared a claim that the vaccines are “gene therapy” — which involves modifying a person’s genes to treat or cure a disease, according to the U.S. Food and Drug Administration.

The posts point to a clip of Dr. Robert Malone — a vocal critic of the COVID-19 vaccines who did early research on mRNA technology — speaking about the shots during a roundtable event hosted by Republican Sen. Ron Johnson in early December. In the clip, Malone is asked whether the vaccines are actually a form of gene therapy.

“As I’ve said repeatedly, it came out of a gene therapy research program,” Malone responds. “These and the adenoviral vectors are absolutely gene therapy technology applied for the purpose of eliciting an immune response.”

A tweet sharing the clip, which was also posted on Instagram, claimed: “The shots are a gene therapy, NOT a vaccine.”

Experts say that’s false.

“It’s just a very different process,” said Dr. Louis Picker, a professor and associate director of the Vaccine and Gene Therapy Institute at Oregon Health & Science University. “The point of gene therapy is to go in and change the actual coding in the DNA of a person’s cells.”

For example, federal officials in November approved the first gene therapy for the blood-clotting disorder hemophilia.

Picker said gene therapy is “a multi-step process that’s very deliberate, it’s very different than just injecting RNA in a carrier that is designed to be picked up, expressed and elicit an immune response,” as the vaccines do.

The COVID-19 vaccines from Pfizer and Moderna use mRNA to instruct cells to make a protein from the coronavirus and trigger an immune response. The Johnson & Johnson vaccine uses a modified adenovirus, a cold virus, to elicit an immune response.

But none of the vaccines can alter humans’ DNA, as the Centers for Disease Control and Prevention explains.

Michael Barry, a Mayo Clinic researcher who studies gene therapy and vaccines, said in an email that tools used for those vaccines have a relationship to gene therapy technology — but that does not mean the vaccines are actually gene therapy.

“The vectors for mRNA vaccines (lipid nanoparticles) are descendants of non-viral vectors called liposomes that were originally developed for gene therapy,” Barry said, referring to the nanoparticles that are used to transport the mRNA to cells.

He said adenovirus vectors — used by the Johnson & Johnson COVID-19 vaccine — were also previously researched for gene therapy.

Still, there are major differences between the COVID-19 vaccines and gene therapy.

“Gene therapy intends to provide long-lasting protein expression to fix a broken gene and its broken protein,” Barry added. “Vaccines intend a short burst of protein expression to stimulate the immune system.”

Malone did not return a request for comment.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 3

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 2

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 1

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 28

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
Fresh Thyme Empowers Local Brands in Michigan Debut

Updated Category News Views 2

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 3

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 1

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
Everpure Surges into the S&P 500: A Milestone Move

Updated Category News Views 10

Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...

Continue Reading

Top 5 Most Recently Viewed Articles

Ashford Hospitality Trust Unveils Reverse Stock Split Strategy

Updated Category News Views 43

Ashford Hospitality Trust Announces Reverse Stock Split Ashford Hospitality Trust, Inc. (NYSE: AHT) has recently made a noteworthy announcement regarding a reverse stock split, approved unanimously by the Board of Directors. This strategic move involves a ratio of 1-for-10, which aims to bolster the company's stock value and ensure compliance with the New York Stock...

Continue Reading
Natural Grocers Explores Growth in Q3 Earnings Announcement

Updated Category News Views 94

Natural Grocers by Vitamin Cottage, Inc. Announces Earnings Call Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is set to release its third quarter fiscal year 2025 financial results shortly after the market closes. Investors can expect this significant announcement to take place on a Thursday in early August. Following this release, the company will host a...

Continue Reading
Standard Motor Products Achieves Sustainability Recognition in 2026

Updated Category News Views 89

Standard Motor Products Celebrates Sustainability Recognition Standard Motor Products, Inc. (NYSE: SMP) is delighted to announce it has been recognized for the third consecutive year as one of America's Most Responsible Companies by Newsweek and Statista. This prestigious acknowledgment highlights the company’s commitment to sustainable and responsible practices within...

Continue Reading
Boeing Contributes $1 Million to Support Presidential Inauguration

Updated Category News Views 278

Boeing's Generous Donation for Presidential Inauguration Boeing, a leading aerospace company, has announced a significant contribution of $1 million to support the inauguration of the U.S. President-elect. This generous act demonstrates Boeing's commitment to participating in national events and supporting leadership transitions. Continuing a Tradition of Support This...

Continue Reading
RxSight, Inc. Faces Legal Scrutiny Amid Financial Declines

Updated Category News Views 107

Investigation Into RxSight, Inc. Pomerantz LLP is conducting an investigation into the claims regarding RxSight, Inc. (NASDAQ: RXST), focusing on whether the company and its executives have engaged in securities fraud or other unlawful business practices that could potentially harm investors. If you have invested in RxSight, it is important to stay informed and proactive....

Continue Reading